Walters Group Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity
Walters Group is > 10% Shareholder of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 13.5 Million shares of ZNTL, which is worth approximately $18 Million. The most recent transaction as insider was on Dec 31, 2025, when has been sold 6,459,973 shares (Common Stock) at a price of $1.2 per share, resulting in proceeds of $7,751,967. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
13.5M
n/a
3M change
n/a
12M change
Total Value Held
$18 Million
WG
Walters Group
> 10% Shareholder
Henderson, NV